Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant

Table 6 Multivariable Cox regression analysis of 28-day mortality in CAPA patients

Variables		P	HR	95% CI
Variables in equation	NLR ≥ 5.7	0.009	2.535	1.257 ~ 5.112
Variables in equation	Number of antibiotics ≥ 3	0.018	2.517	1.170 ~ 5.413
Variables not in equation	Age	0.731
	Sex	0.218
	Diabetes	0.243
	Chronic obstructive pulmonary disease	0.421
	Immunocompromised status	0.100
	CRP ≥ 50 mg/L	0.182
	Tocilizumab	0.911
	Cumulative glucocorticoid dose* ≥1500 mg	0.981

Bold values represent p < 0.05, indicating statistical significance
Abbreviations: CAPA, COVID-19-associated pulmonary aspergillosis; NLR, neutrophil-lymphocyte ratio; CRP, C-reactive protein; HR, hazard ratio; CI, confidence interval; *Hydrocortisone dose was taken as reference

ISSN: 1471-2334